A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure
Clinical trial NCT02772029 · UNKNOWN
Trial details
- NCT number
- NCT02772029
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.